Cargando…
Humoral immune response after different SARS-CoV-2 vaccination regimens
BACKGROUND: The humoral immune response after primary immunisation with a SARS-CoV-2 vector vaccine (AstraZeneca AZD1222, ChAdOx1 nCoV-19, Vaxzevria) followed by an mRNA vaccine boost (Pfizer/BioNTech, BNT162b2; Moderna, m-1273) was examined and compared with the antibody response after homologous v...
Autores principales: | Rose, Ruben, Neumann, Franziska, Grobe, Olaf, Lorentz, Thomas, Fickenscher, Helmut, Krumbholz, Andi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776512/ https://www.ncbi.nlm.nih.gov/pubmed/35057798 http://dx.doi.org/10.1186/s12916-021-02231-x |
Ejemplares similares
-
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
por: Neumann, Franziska, et al.
Publicado: (2021) -
Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection
por: Strömer, Annabelle, et al.
Publicado: (2020) -
Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen
por: Strömer, Annabelle, et al.
Publicado: (2020) -
Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection
por: Rose, Ruben, et al.
Publicado: (2022) -
The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade
por: Geisen, Ulf Martin, et al.
Publicado: (2022)